EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 07 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list
|
NYLOSTAB S-EED; NYSEED
|
419-710-0
|
42774-15-2
|
Acute Tox. 4; Eye Irrit. 2 |
||
|
202-464-1
|
95-92-1
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
253-718-3
|
37924-13-3
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
PK 323
|
401-940-8
|
-
|
Acute Tox. 4; Eye Irrit. 2 |
||
|
247-554-1
|
26259-45-0
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
AZYLACID-POTASSIUMSALT
|
401-630-2
|
96566-70-0
|
Acute Tox. 4; Eye Irrit. 2; STOT SE 3 |
||
|
610-700-3
|
51580-86-0
|
Acute Tox. 4; Eye Irrit. 2; STOT SE 3 |
|||
|
202-425-9
|
95-50-1
|
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||
|
202-273-3
|
93-76-5
|
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||
|
233-307-5
|
10112-91-1
|
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||